Gamunex (Talecris Biotherapeutics)
Brand names,
Gamunex (Talecris Biotherapeutics)
Analogs
Gamunex (Talecris Biotherapeutics)
Brand Names Mixture
Gamunex (Talecris Biotherapeutics)
Chemical_Formula
C6332H9826N1692O1980S42
Gamunex (Talecris Biotherapeutics)
RX_link
http://www.rxlist.com/cgi/generic2/baygam.htm
Gamunex (Talecris Biotherapeutics)
fda sheet
Gamunex (Talecris Biotherapeutics)
msds (material safety sheet)
Gamunex (Talecris Biotherapeutics)
Synthesis Reference
No information avaliable
Gamunex (Talecris Biotherapeutics)
Molecular Weight
142682.3
Gamunex (Talecris Biotherapeutics)
Melting Point
61 oC (FAB fragment), 71 oC (whole mAb) - Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).
Gamunex (Talecris Biotherapeutics)
H2O Solubility
No information avaliable
Gamunex (Talecris Biotherapeutics)
State
Liquid
Gamunex (Talecris Biotherapeutics)
LogP
-0.331
Gamunex (Talecris Biotherapeutics)
Dosage Forms
Solution
Gamunex (Talecris Biotherapeutics)
Indication
For treatment of immunodeficiencies, thrombocytopenic purpura, Kawasaki disease, gammablobulinemia, leukemia, bone transplant
Gamunex (Talecris Biotherapeutics)
Pharmacology
Used as a replacement therapy in inherited humoral immunodeficiency disorders such as severe combined immunodeficiency syndrome, x-linked agammaglobulinemia, and Wiskott-Aldrich Syndrome. The immune globulins target, bind and kill bacterial cells as well as viral particles. IgG is the monomeric immunoglobulin of which there are four subclasses (IgG1, IgG2, IgG3 and IgG4) in differing abundances (66%, 23%, 7% and 4%). IgAs represent about 15% of the immunoglobulins in the blood. These target inhaled or ingested pathogens.
Gamunex (Talecris Biotherapeutics)
Absorption
No information avaliable
Gamunex (Talecris Biotherapeutics)
side effects and Toxicity
No information avaliable
Gamunex (Talecris Biotherapeutics)
Patient Information
No information avaliable
Gamunex (Talecris Biotherapeutics)
Organisms Affected
No information avaliable